Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MGAWN1 in West Nile Virus Infection
NCT00927953Phase 2Terminated
- Sponsor
- MacroGenics
- Start
- May 2009
- Primary completion
- Feb 2011
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of MGAWN1 in West Nile virus infection (WNV), sponsored by MacroGenics. Started May 2009; status: terminated.
02
Drugs
MGAWN1
03
Conditions
West Nile virus infection (WNV)
Beyond the preview
Go deeper on NCT00927953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927953.